©The Author(s) 2026.
World J Gastrointest Endosc. Jan 16, 2026; 18(1): 114791
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.114791
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.114791
Table 3 Oncologic outcomes, mean ± SD
| Indicator | LPD group (n = 50) | OPD group (n = 50) | t/χ2 | P value | MD/OR/HR (95%CI) |
| Lymph nodes retrieved | 14 ± 5 | 13 ± 4 | 0.75 | 0.45 | MD 1 (-0.77 to 2.77) |
| R0 resection (no/yes) | 4/46 | 6/44 | 0.34 | 0.56 | OR 1.57 (0.41 to 5.93) |
| Median OS [months (95%CI)] | 22 (19-25) | 20 (17-23) | 0.65 | HR 0.92 (0.65 to 1.31) | |
| 12-month RFS (%) | 78 | 72 | 0.48 | HR 0.78 (0.35 to 1.74) | |
| Adjuvant completion (no/yes) | 8/42 (84%) | 10/40 (80%) | 0.24 | 0.62 | OR 1.31 (0.47 to 3.66) |
- Citation: Kalim M, Sarwar M, Chishti SSA, Ali M, Qayyum S, Ahmed J, Memon M, Shenawa E. Comparative outcomes of laparoscopic vs open pancreaticoduodenectomy in early-stage pancreatic cancer. World J Gastrointest Endosc 2026; 18(1): 114791
- URL: https://www.wjgnet.com/1948-5190/full/v18/i1/114791.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i1.114791